Cardiogenic Shock
📧 Sign up to get email alerts when something new happens for Cardiogenic Shock.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-11-12Clinical Trial Update: Establishing Physiologic Outcomes for Ventricular Unloading on VA ECMO
A clinical trial evaluating physiologic outcomes for ventricular unloading on VA ECMO, targeting patients with cardiogenic shock, has been w…
-
CLINICAL_TRIALS withdrawal · 2024-10-23Clinical Trial Update: Study on Early Intra-aortic Balloon Pump Placement in Acute Decompensated Heart Failure Complicated by Cardiogenic Shock [Phase 4]
A Phase 4 trial evaluating early intra-aortic balloon pump placement in acute decompensated heart failure with cardiogenic shock has been te…
-
CLINICAL_TRIALS withdrawal · 2024-07-19Clinical Trial Update: Awake Axillary Impella 5.5 Placement - A Feasibility Trial [NA]
The feasibility trial evaluating awake axillary placement of the Impella 5.5 in cardiogenic shock has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-10-05Clinical Trial Update: Comparison of ARNI to Alternate Oral Vasodilator Therapies in Patients With Low Cardiac Output [Phase 4]
A Phase 4 trial comparing ARNI to other oral vasodilator therapies in patients with cardiogenic shock was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-03-16Clinical Trial Update: Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock [Phase 2]
A Phase 2 clinical trial evaluating cyclosporine in acute myocardial infarction complicated by cardiogenic shock has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.